News

Technology News

ARROW Endurance Catheter Gets FDA Clearance

Thursday, July 30, 2015 5:00:00 AM PDT | VentureDeal
   Wayne, Pennsylvania  --  Teleflex (NYSE: TFX) announced that its new peripheral catheter system has received market clearance by the FDA.

Called the ARROW Endurance Extended Dwell Peripheral Catheter System, the medical device enables doctors to avoid using multiple PIVs and instead substitute its catheter for dwell time of up to 29 days.

The catheter is an intravascular catheter designed to permit delivery of various infusion therapies, pressure monitoring, injection and blood withdrawal.

Teleflex designed the system in order to increase clinician safety and reduce needle sticks for patients, by containing a passive needle safety system that reduces accidental needle stick injuries.

The catheter also features a closed system that makes it much more difficult for clinicians to come into contact with blood-borne pathogens.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1